Overview
Swiss equity market dominated by Nestle, Novartis, and Roche — nearly 50% of the fund. Defensive quality blue-chips with global revenues. Swiss franc provides safe-haven currency diversification vs USD.
Top Holdings
| Ticker | Holding | Weight |
|---|---|---|
| NESN | Nestle S.A. | 22.4% |
| NOVN | Novartis AG | 14.8% |
| ROG | Roche Holding | 12.4% |
| UBSG | UBS Group AG | 8.4% |
| ABBN | ABB Ltd. | 6.8% |
| ZURN | Zurich Insurance | 5.8% |
| GIVN | Givaudan SA | 4.4% |
| LONN | Lonza Group | 3.8% |
| GEBN | Geberit AG | 3.4% |
| PGHN | Partners Group | 2.9% |
Fund Details
Investment Thesis
Switzerland's equity market is defined by extraordinary corporate quality. Nestle, Novartis, and Roche together represent nearly 50% of EWL and are three of the most defensively positioned companies in the world. Swiss companies are renowned for consistent earnings, conservative balance sheets, and shareholder-friendly capital allocation. The Swiss franc has been one of the most stable and appreciating currencies globally, providing additional return potential for USD-based investors. EWL combines defensive healthcare and consumer staples characteristics with precision engineering and financial services sectors.
Who It's For
Conservative investors seeking defensive international equity exposure with some of the world's highest-quality companies and a historically strong currency. EWL suits those wanting healthcare and consumer staples sector exposure through globally dominant Swiss companies at international valuations. CHF appreciation potential provides an additional return driver, making EWL attractive during periods of US dollar weakness.
10-Year History
| Year | Close | % Chg |
|---|---|---|
| 2016 | $38.42 | -- |
| 2017 | $44.82 | +16.7% |
| 2018 | $39.82 | -11.2% |
| 2019 | $46.82 | +17.6% |
| 2020 | $48.42 | +3.4% |
| 2021 | $52.82 | +9.1% |
| 2022 | $44.42 | -15.9% |
| 2023 | $50.82 | +14.4% |
| 2024 | $49.82 | -2.0% |
| 2025 | $57.80 | +16.0% |
| Year | Yield |
|---|---|
| 2016 | 2.42% |
| 2017 | 2.22% |
| 2018 | 2.52% |
| 2019 | 2.32% |
| 2020 | 2.02% |
| 2021 | 1.82% |
| 2022 | 2.32% |
| 2023 | 2.12% |
| 2024 | 2.22% |
| 2025 | 2.42% |
| Year | AUM | % Chg |
|---|---|---|
| 2016 | $2.4B | -- |
| 2017 | $3.0B | +25.0% |
| 2018 | $2.4B | -20.0% |
| 2019 | $2.8B | +16.7% |
| 2020 | $2.8B | 0.0% |
| 2021 | $3.2B | +14.3% |
| 2022 | $2.4B | -25.0% |
| 2023 | $2.8B | +16.7% |
| 2024 | $2.8B | 0.0% |
| 2025 | $2.1B | -25.0% |
Historical figures are ETFHub estimates modelled from asset-class return patterns and may differ from official fund records. Data as of August 2026.
Related Country ETFs ETFs
Markets. Intelligence. Daily.
Full briefs on 251 ETFs, curated daily ETF news, and a free weekly deep-dive newsletter — all on ETFHub.
Get the Free Weekly Brief Explore the ETF Portal Official Fund Page →